Comparison of the results for three automated immunoassay systems in determining serum HBV markers

Clinica Chimica Acta

Volumn 372, Issue 1-2, 2006, Pages 129-133

  Chen, Yu ^a   Wu, Wei ^a   Li, Lan juan ^a   Lou, Bin ^a   Zhang, Jie ^a   Fan, Jian ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Correlation; Hepatitis B; Immunoassay

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN;

ADULT; AGED; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; AUTOANALYZER; AUTOMATION; BLOOD ANALYSIS; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEPATITIS B VIRUS; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VIRUS EXAMINATION;

ADOLESCENT; ADULT; AUTOMATION; BIOLOGICAL MARKERS; DOUBLE-BLIND METHOD; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED;

HEPATITIS B VIRUS;

EID: 33748139369     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.03.032     Document Type: Article

References (14)

1. Weber B., Dengler T., Berger A., Doerr H.W., and Rabenau H. Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg. J Clin Microbiol 41 1 (2003) 135-143
2. Taylor P., Pickard G., Gammie A., and Atkins M. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay analyzers for a routine diagnostic virology laboratory. J Clin Virol 30 Suppl (2004) S11-S15
3. Kohmoto M., Enomoto M., Tamori A., et al. Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers. J Med Virol 75 2 (2005) 235-239
4. Deguchi M., Yamashita N., Kagita M., et al. Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay. J Virol Methods 115 2 (2004) 217-222
5. Chen C.H., Lee C.M., Wang J.H., Tung H.D., Hung C.H., and Lu S.N. Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers. Eur J Gastroenterol Hepatol 16 11 (2004) 1213-1218
6. Luo K.X., Zhou R., He C., Liang Z.S., and Jiang S.B. Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen. J Med Virol 35 1 (1991) 55-59
7. Torbenson M., Kannangai R., Astemborski J., Strathdee S.A., Vlahov D., and Thomas D.L. High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology 39 1 (2004) 51-57
8. Weber B., Melchior W., Gehrke R., Doerr H.W., Berger A., and Rabenau H. Hepatitis B virus markers in anti-HBc only positive individuals. J Med Virol 64 3 (2001) 312-319
9. Weber B. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol 32 2 (2005) 102-112
10. Roque-Afonso A.M., Feray C., Samuel D., et al. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors. Gut 50 1 (2002) 95-99
11. Maynard M., Parvaz P., Durantel S., et al. Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failure. J Hepatol 42 2 (2005) 279-281
12. Heijtink R.A., Schneeberger P.M., Postma B., and Crombach W. Anti-HBs levels after hepatitis B immunisation depend on test reagents: routinely determined 10 and 100 IU/l seroprotection levels unreliable. Vaccine 20 (2002) 2899-2905
13. Heijtink R.A., Janssen H.L., Hop W.C., Osterhaus A.D., and Schalm S.W. Interferon-alpha therapy for chronic hepatitis B: early response related to pre-treatment changes in viral replication. J Med Virol 63 3 (2001) 217-219
14. Heijtink R.A., Kruining J., Honkoop P., et al. Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B. J Med Virol 53 3 (1997) 282-287